ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 177 filers reported holding ACCELERON PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $231,000 | +3.6% | 1,682 | -5.5% | 0.00% | – |
| Q2 2021 | $223,000 | -7.9% | 1,780 | 0.0% | 0.00% | – |
| Q1 2021 | $242,000 | -23.2% | 1,780 | -27.9% | 0.00% | -100.0% |
| Q4 2020 | $315,000 | +12.5% | 2,468 | -0.6% | 0.00% | 0.0% |
| Q3 2020 | $280,000 | -92.4% | 2,484 | -93.6% | 0.00% | -85.7% |
| Q2 2020 | $3,691,000 | -54.8% | 38,747 | -57.4% | 0.01% | -61.1% |
| Q1 2020 | $8,168,000 | +3420.7% | 90,895 | +1972.4% | 0.02% | – |
| Q4 2019 | $232,000 | +5.0% | 4,386 | -7.3% | 0.00% | – |
| Q1 2019 | $221,000 | -73.1% | 4,733 | -67.1% | 0.00% | -100.0% |
| Q3 2018 | $823,000 | -63.3% | 14,379 | -68.9% | 0.00% | -66.7% |
| Q2 2018 | $2,245,000 | -48.3% | 46,273 | -58.3% | 0.00% | -57.1% |
| Q1 2018 | $4,344,000 | -37.2% | 111,093 | -30.6% | 0.01% | -22.2% |
| Q4 2017 | $6,916,000 | +128.7% | 160,110 | +97.6% | 0.01% | +125.0% |
| Q3 2017 | $3,024,000 | +60.7% | 81,010 | +9.9% | 0.00% | +33.3% |
| Q4 2016 | $1,882,000 | -29.6% | 73,730 | -0.1% | 0.00% | -25.0% |
| Q3 2016 | $2,672,000 | -3.5% | 73,830 | -9.4% | 0.00% | -20.0% |
| Q2 2016 | $2,770,000 | +16.4% | 81,500 | -9.6% | 0.01% | +25.0% |
| Q1 2016 | $2,380,000 | -29.0% | 90,200 | +31.3% | 0.00% | -33.3% |
| Q4 2015 | $3,350,000 | – | 68,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 2 | $358 | 0.00% |